SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

Search

Pharming Group NV

Chiusa

0.862 -1.71

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

0.86

Massimo

0.864

Metriche Chiave

By Trading Economics

Entrata

-18M

-15M

Vendite

-14M

79M

EPS

-0.02

Margine di Profitto

-18.61

Dipendenti

404

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+13.73% upside

Dividendi

By Dow Jones

Utili prossimi

31 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-17M

592M

Apertura precedente

2.57

Chiusura precedente

0.862

Pharming Group NV Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 lug 2025, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 lug 2025, 17:28 UTC

I principali Market Mover

SharpLink Gaming Gains on Ethereum Purchase

11 lug 2025, 16:57 UTC

Utili

BASF Cuts Outlook on Global Economy Uncertainty

12 lug 2025, 17:01 UTC

Utili

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

12 lug 2025, 14:53 UTC

Utili

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

12 lug 2025, 02:24 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 lug 2025, 02:05 UTC

Acquisizioni, Fusioni, Takeovers

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 lug 2025, 21:45 UTC

Discorsi di Mercato

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 lug 2025, 19:46 UTC

Acquisizioni, Fusioni, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 lug 2025, 19:45 UTC

Discorsi di Mercato

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 lug 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 lug 2025, 18:18 UTC

Discorsi di Mercato

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 lug 2025, 17:35 UTC

Discorsi di Mercato

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 lug 2025, 17:26 UTC

Discorsi di Mercato

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 lug 2025, 16:53 UTC

Discorsi di Mercato

Crude Futures Add to Early Gains -- Market Talk

11 lug 2025, 16:42 UTC

Utili

BASF Cuts Outlook on Global Economic Uncertainty

11 lug 2025, 16:08 UTC

Discorsi di Mercato

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 lug 2025, 16:05 UTC

Utili

BASF Will Publish Half-Year Results on July 30

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 lug 2025, 16:03 UTC

Utili

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 lug 2025, 16:02 UTC

Utili

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 lug 2025, 16:01 UTC

Utili

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 lug 2025, 16:00 UTC

Utili

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 lug 2025, 15:59 UTC

Utili

BASF Cuts 2025 Earnings View

11 lug 2025, 15:58 UTC

Utili

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 lug 2025, 15:57 UTC

Utili

BASF 2Q EBIT Before Special Items EUR810M

11 lug 2025, 15:54 UTC

Utili

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

Confronto tra pari

Modifica del prezzo

Pharming Group NV Previsione

Obiettivo di Prezzo

By TipRanks

13.73% in crescita

Previsioni per 12 mesi

Media 1.001 EUR  13.73%

Alto 1 EUR

Basso 1 EUR

Basato su 1 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pharming Group NV - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

1 ratings

0

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.